Crism Therapeutics
(LSE) CRTX
Crism Therapeutics Financials at a Glance
Market Cap
$594.96M
Revenue (TTM)
$0.00
Net Income (TTM)
$4.00M
EPS (TTM)
$-4.66
P/E Ratio
-2.47
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$0.12
Volume
71,134
Open
$11.16
Price
$0.12
Volume
71,134
Open
$11.16
Previous Close
$11.55
Daily Range
$11.00 - $12.00
52-Week Range
$8.00 - $29.40
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$0.12
Volume
71,134
Open
$11.16
Previous Close
$11.55
Daily Range
$11.00 - $12.00
52-Week Range
$8.00 - $29.40
CRTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Crism Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Andrew James Webb
Website
www.crismtherapeutics.comHeadquarters
Road Town, VG
CRTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-88%
Return on Capital
-69%
Return on Assets
-54%
Earnings Yield
-40.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$594.96M
Shares Outstanding
51.74M
Volume
71.13K
Short Interest
0.00%
Avg. Volume
361.04K
Financials (TTM)
Gross Profit
$21.00K
Operating Income
$582.00K
EBITDA
$566.00K
Operating Cash Flow
$933.00K
Capital Expenditure
$28.00K
Free Cash Flow
$961.00K
Cash & ST Invst.
$1.28M
Total Debt
$0.00
Crism Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.12K
N/A
Gross Margin
0.00%
N/A
Market Cap
$594.96M
N/A
Market Cap/Employee
$148.74M
N/A
Employees
4
N/A
Net Income
$1.28M
-14.8%
EBITDA
$1.24M
-32.5%
Quarterly Fundamentals
Net Cash
$479.03K
-91.7%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-53.60%
N/A
Return on Invested Capital
-69.31%
N/A
Free Cash Flow
$1.19M
+45.4%
Operating Cash Flow
$1.19M
+45.4%